A patient is given succinylcholine chloride that is going to receive electroconvulsive therapy. The nurse mus… - NORCET 5 Prelims - Sept 2023 (Shift-1)

NORCET 5 Prelims - Sept 2023 (Shift-1)

Pharmacology

Medium

Appeared in: NORCET 5 Prelims - Sept 2023 (Shift-1)

Explanation

Succinylcholine is a depolarizing neuromuscular blocking agent, also known as a muscle relaxant.
In the context of Electroconvulsive Therapy (ECT), it is administered to induce temporary, profound muscle relaxation.
The primary goal is to prevent the strong motor convulsions that occur during the induced seizure.
By preventing these convulsions, succinylcholine significantly reduces the risk of musculoskeletal injuries, such as bone fractures and dislocations, which were a common complication of ECT before the use of muscle relaxants.

Option A: Reducing anxiety is the role of anxiolytic medications (e.g., benzodiazepines), not neuromuscular blockers. Succinylcholine paralyzes muscles but does not have a calming or anti-anxiety effect.
Option B: Succinylcholine does not produce an anesthetic effect; it does not cause loss of consciousness. Administering it to a conscious patient would result in terrifying paralysis without sedation.
Option C: Reducing secretions is the function of anticholinergic medications. These drugs block muscarinic receptors to decrease saliva and respiratory secretions.

Visual 1: Table: Medications Used in ECT - A table listing the drug class (e.g., Muscle Relaxant, Anesthetic, Anticholinergic), specific drug names (e.g., Succinylcholine, Propofol, Atropine), and their primary purpose during the procedure. This helps differentiate the roles of each medication.

Clinical Relevance

Nursing practice connection: Knowing Pharmacology in Electroconvulsive Therapy (ECT) helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
The nurse's primary role is to ensure patient safety. This includes monitoring the patient's respiratory status after succinylcholine administration, as it causes temporary apnea (cessation of breathing), requiring manual or mechanical ventilation until the drug wears off.
Nurses must be vigilant for adverse effects, particularly malignant hyperthermia, a rare but life-threatening reaction to succinylcholine and certain anesthetics, characterized by high fever, muscle rigidity, and tachycardia.
What if? If a patient has a known or suspected history of pseudocholinesterase deficiency, succinylcholine would be contraindicated. This enzyme deficiency impairs the metabolism of succinylcholine, leading to prolonged paralysis and apnea. An alternative non-depolarizing muscle relaxant like rocuronium would be used instead.

How to Approach the Question

First, identify the core components of the question: the drug (succinylcholine chloride) and the clinical context (Electroconvulsive Therapy - ECT).
Recall the classification of succinylcholine. It is a neuromuscular blocking agent, or muscle relaxant.
Think about the ECT procedure. It involves inducing a generalized seizure. What are the risks of an unmodified seizure? The primary physical risk is violent muscle contractions leading to injury.
Connect the drug's function to the procedure's risk. A muscle relaxant would prevent these violent contractions.
Evaluate the options based on this connection. 'For muscle relaxation' directly addresses the primary safety concern of ECT that succinylcholine is meant to solve.
Differentiate this from the roles of other drugs used in ECT: anesthetics for unconsciousness and anticholinergics for secretion control.

Concept Tested & Keywords

Qayfpa-u7YAeCeqqTg9rm_